Close Menu


The award supports work by the company — whose technology was developed in the lab of Harvard professor George Whitesides — and electronics company MC10 to develop the technology for HIV detection in nations with limited access to laboratory diagnostics equipment.

At last week's Sample Prep 2010 meeting in Baltimore, Md., microfluidics, integration, and automation were oft-cited as future market drivers in the area of sample prep for virus, toxin, and pathogen detection.

Life Tech officials said that Stokes Bio's microfluidics-based technology platform will enable high-throughput, PCR-based genetic analyses for a variety of applications, particularly in the area of agricultural biology.

Access will offer its web-based software with the Caliper LabChip GX system as an integrated molecular diagnostic platform.

Luminex's acquisition of BSD Robotics will provide it with new technologies in automation and robotics in the field of dry sample handling.

New Products: Feb 23, 2010


Applied Biosystems 3500 Series Genetic Analyzer, Caliper's LabChip XT, Febit's HybSelector

The partnership will combine Fluidigm's microfluidic platforms with OncoMed's cancer stem cell sorting technology to study highly tumorigenic cell populations.

Fluidigm is seeking to raise up to a total of $24.1 million from the private offering, according to the SEC filing.

The company plans to use the funding to commercialize its Apollo 100 system, a sample-preparation system for Sanger sequencing, and to develop the Apollo platform for the next-generation sequencing markets as well as for DNA-based human identification and forensics.

The school will study the feeding mechanisms in butterflies to develop flexible ways to remove and transport liquids from cells and tissues.


New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.